The past few weeks have been hard on many traders. Most are looking at a sea of red in their portfolios. This...
6 endpoints met after full data release so shorts double down on trial failure narrative Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...
Alex Carlson, the Editor-in-Chief of InsiderFinancial.com, covers the last week and the penny stock outlook for the coming week. BOTTOM LINE As...
We know it’s been a painful few weeks as many names have gotten crushed. On the OTC Markets, some penny stocks are...
Early projections were announced in early January that Kaival Brands (OTCMKTS: KAVL) could do $400-$450M in revenues for 2021, but we feel...
The past two weeks have been hard for OTC traders. We have all seen the value of our holdings drop in the...
Alex Carlson, the Editor-in-Chief of InsiderFinancial.com, covers the last week on OTC Markets and the OTC Markets outlook for the coming week....
